Your browser doesn't support javascript.
loading
Unrecognized fluid overload during induction therapy increases morbidity in patients with acute promyelocytic leukemia.
Chamoun, Kamal; Kantarjian, Hagop M; Wang, Xuemei; Naqvi, Kiran; Aung, Fleur; Garcia-Manero, Guillermo; Borthakur, Gautam; Jabbour, Elias; Kadia, Tapan; Daver, Naval; DiNardo, Courtney D; Jain, Nitin; Konopleva, Marina; Cortes, Jorge; Ravandi, Farhad; Yilmaz, Musa.
Afiliação
  • Chamoun K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Aung F; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cortes J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 125(18): 3219-3224, 2019 09 15.
Article em En | MEDLINE | ID: mdl-31150121

Texto completo: 1 Coleções: 01-internacional Temas: Promover_ampliacao_atencao_especializada Contexto em Saúde: 11_ODS3_cobertura_universal Base de dados: MEDLINE Assunto principal: Desequilíbrio Hidroeletrolítico / Leucemia Promielocítica Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Transfusão de Componentes Sanguíneos / Unidades de Terapia Intensiva / Intubação Intratraqueal Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Promover_ampliacao_atencao_especializada Contexto em Saúde: 11_ODS3_cobertura_universal Base de dados: MEDLINE Assunto principal: Desequilíbrio Hidroeletrolítico / Leucemia Promielocítica Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Transfusão de Componentes Sanguíneos / Unidades de Terapia Intensiva / Intubação Intratraqueal Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2019 Tipo de documento: Article